Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Jason E. Stadanlick"'
Autor:
Astero Klampatsa, Shaun M. O’Brien, Jeffrey C. Thompson, Abhishek S. Rao, Jason E. Stadanlick, Marina C. Martinez, Maria Liousia, Edward Cantu, Keith Cengel, Edmund K. Moon, Sunil Singhal, Evgeniy B. Eruslanov, Steven M. Albelda
Publikováno v:
OncoImmunology, Vol 8, Iss 9 (2019)
Given the growing interest and promising preliminary results of immunotherapy in malignant pleural mesothelioma (MPM), it has become important to more fully understand the immune landscape in this tumor. This may be especially relevant in deciding wh
Externí odkaz:
https://doaj.org/article/278924de4ef344fba6aca323b62dccba
Autor:
David L. Wiest, Joseph R. Testa, Shawn P. Fahl, Sang-Yun Lee, Nehal Solanki-Patel, Noa Greenberg-Kushnir, Jason E. Stadanlick, Kathy Q. Cai, Shuyun Rao
This file contains supplementary figures 1-4. Supplementary Figure 1 provides supporting information for the effects of Rpl22 loss on thymic cellularity and supports Figure 1. Supplementary Figure 2 describes the phenotypes of periperhal T lineage ce
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7be51f3c5706a37ce093a350655aac74
https://doi.org/10.1158/0008-5472.22408754.v1
https://doi.org/10.1158/0008-5472.22408754.v1
Autor:
David L. Wiest, Joseph R. Testa, Shawn P. Fahl, Sang-Yun Lee, Nehal Solanki-Patel, Noa Greenberg-Kushnir, Jason E. Stadanlick, Kathy Q. Cai, Shuyun Rao
Mutations in ribosomal proteins cause bone marrow failure syndromes associated with increased cancer risk, but the basis by which they do so remains unclear. We reported previously that the ribosomal protein Rpl22 is a tumor suppressor in T-cell acut
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::b370b916dbf257b2ab3e978194df3dce
https://doi.org/10.1158/0008-5472.c.6507608.v1
https://doi.org/10.1158/0008-5472.c.6507608.v1
Autor:
David L. Wiest, Joseph R. Testa, Shawn P. Fahl, Sang-Yun Lee, Nehal Solanki-Patel, Noa Greenberg-Kushnir, Jason E. Stadanlick, Kathy Q. Cai, Shuyun Rao
This file contains the legends fro supplementary figures 1-4.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::530167661387587b6ece3834749e2f97
https://doi.org/10.1158/0008-5472.22408757
https://doi.org/10.1158/0008-5472.22408757
Publikováno v:
Blood. 94:3922-3927
Solvent/detergent (S/D)-treated plasma is currently marketed by the American Red Cross as a virally inactivated alternative to fresh-frozen plasma (FFP). The serpin-type serine proteinase inhibitors have a flexible reactive site loop (RSL) that can c
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::0c6e0399ce2dd43ac09568249781d910
https://doi.org/10.1182/blood.v94.11.3922.423k33_3922_3927
https://doi.org/10.1182/blood.v94.11.3922.423k33_3922_3927
Autor:
Jason E. Stadanlick, Karen A. Hasty, Connie L. Hall, Dennis J. Dietzen, J. Marcus Lockett, Alan E. Mast
Publikováno v:
The Journal of biological chemistry. 275(41)
Tissue factor pathway inhibitor (TFPI) is a Kunitz-type serine proteinase inhibitor that down-regulates tissue factor-initiated blood coagulation. The most biologically active pool of TFPI is associated with the vascular endothelium, however, the bio
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0038471fabc1cd7a36a99a97a50737e6
https://pubmed.ncbi.nlm.nih.gov/10922378
https://pubmed.ncbi.nlm.nih.gov/10922378
Publikováno v:
The Journal of Immunology. 178:S112-S112
Signaling through both the B cell receptor (BCR) and the BLyS receptor, BR3, are required for primary B cell survival. Therefore, understanding how the downstream signaling pathways from these receptors interact should help reveal the molecular mecha
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::21cb30c24ba7057e32128ab095e9e1f4
https://doi.org/10.4049/jimmunol.178.supp.83.2
https://doi.org/10.4049/jimmunol.178.supp.83.2